Basic Considerations for the Use of Monoclonal Antibodies in Migraine

Por Levin, Morris, Silberstein, Stephen D., Gilbert, Robert, Lucas, Sylvia, Munsie, Leanne, Garrelts, Alyssa, Kennedy, Kate, Everman, Nicole, Pearlman, Eric
Publicado no Headache (2018)

Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex

Por Smith, Ryan M., Papp, Audrey C., Webb, Amy, Ruble, Cara L., Munsie, Leanne M., Nisenbaum, Laura K., Kleinman, Joel E., Lipska, Barbara K., Sadee, Wolfgang
Publicado em 2012

Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

Por Nisenbaum, Laura K., Downing, AnnCatherine M., Zhao, Fangyi, Millen, Brian A., Munsie, Leanne, Kinon, Bruce J., Adams, David H., Gomez, Juan Carlos, Penny, Michelle Ann
Publicado no J Pers Med (2016)

Gain and loss of function of P2X(7) receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain

Por Ursu, Daniel, Ebert, Philip, Langron, Emily, Ruble, Cara, Munsie, Leanne, Zou, Wei, Fijal, Bonnie, Qian, Yue-Wei, McNearney, Terry A, Mogg, Adrian, Grubisha, Olivera, Merchant, Kalpana, Sher, Emanuele
Publicado em 2014

Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons

Por Ruble, Cara L., Smith, Ryan M., Calley, John, Munsie, Leanne, Airey, David C., Gao, Yuan, Shin, Joo Heon, Hyde, Thomas M., Straub, Richard E., Weinberger, Daniel R., Nisenbaum, Laura K.
Publicado no BMC Genet (2016)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Por Goldman, Jennifer G., Forsberg, Leah K., Boeve, Bradley F., Armstrong, Melissa J., Irwin, David J., Ferman, Tanis J., Galasko, Doug, Galvin, James E., Kaufer, Daniel, Leverenz, James, Lippa, Carol F., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael, Keller, Bill, Munsie, Leanne, Nakagawa, Masaki, Taylor, Angela, Graham, Todd
Publicado no Alzheimers Res Ther (2020)

Genome-wide association study of rate of cognitive decline in Alzheimer’s Disease patients identifies novel genes and pathways

Por Sherva, Richard, Gross, Alden, Mukherjee, Shubhabrata, Koesterer, Ryan, Amouyel, Philippe, Bellenguez, Celine, Dufouil, Carole, Bennett, David A., Chibnik, Lori, Cruchaga, Carlos, del-Aguila, Jorge, Farrer, Lindsay A., Mayeux, Richard, Munsie, Leanne, Winslow, Ashley, Newhouse, Stephen, Saykin, Andrew J., Kauwe, John S.K., Crane, Paul K., Green, Robert C.
Publicado no Alzheimers Dement (2020)

Genetic Studies of Quantitative MCI and AD Phenotypes in ADNI: Progress, Opportunities, and Plans

Por Saykin, Andrew J., Shen, Li, Yao, Xiaohui, Kim, Sungeun, Nho, Kwangsik, Risacher, Shannon L., Ramanan, Vijay K., Foroud, Tatiana M., Faber, Kelly M., Sarwar, Nadeem, Munsie, Leanne M., Hu, Xiaolan, Soares, Holly D., Potkin, Steven G., Thompson, Paul M., Kauwe, John S.K., Kaddurah-Daouk, Rima, Green, Robert C., Toga, Arthur W., Weiner, Michael W.
Publicado no Alzheimers Dement (2015)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers

Por Shen, Li, Thompson, Paul M., Potkin, Steven G., Bertram, Lars, Farrer, Lindsay A., Foroud, Tatiana M., Green, Robert C., Hu, Xiaolan, Huentelman, Matthew J., Kim, Sungeun, Kauwe, John S. K., Li, Qingqin, Liu, Enchi, Macciardi, Fabio, Moore, Jason H., Munsie, Leanne, Nho, Kwangsik, Ramanan, Vijay K., Risacher, Shannon L., Stone, David J., Swaminathan, Shanker, Toga, Arthur W., Weiner, Michael W., Saykin, Andrew J.
Publicado em 2013